Circulating Exosomal MicroRNA-21 As a Potential Biomarker That May Predict Response to Azacitidine Treatment in Myelodysplastic Syndromes

被引：0
|
作者：
Min, Yoo-Hong [1 ]
Yoon, Sulhee [1 ]
Hwang, Doh Yu [1 ]
Kim, Yundeok [1 ]
Kim, Yeo-Kyeoung [2 ]
Kim, Yuri [1 ]
Cho, Jae Yong [1 ]
Kim, Jin Seok [1 ]
Kim, Soo Jeong [1 ]
Cheong, June-Won [1 ]
Kim, Hyeoung Joon [2 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Chonnam Natl Univ, Dept Internal Med, Hwasun, South Korea
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1625 / 1625
页数：1
相关论文
共 50 条
  • [1] Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes
    Kim, Yundeok
    Cheong, June-Won
    Kim, Yeo-Kyeoung
    Eom, Ju-In
    Jeung, Hoi-Kyung
    Kim, Soo Jeong
    Hwang, Dohyu
    Kim, Jin Seok
    Kim, Hyeuong Joon
    Min, Yoo Hong
    PLOS ONE, 2014, 9 (02):
  • [2] CIRCULATING SERUM MICRORNA-21 PREDICTS SURVIVAL AND RESPONSE TO HYPOMETHYLATING AGENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Lee, J. Y.
    Kim, S. J.
    Kim, Y.
    Hwang, D. Y.
    Hyun, S. Y.
    Jang, J. E.
    Cheong, J. W.
    Kim, J. S.
    Min, Y. H.
    HAEMATOLOGICA, 2014, 99 : 82 - 83
  • [3] Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
    Tsukamoto, Mitsuo
    Iinuma, Hisae
    Yagi, Takahiro
    Matsuda, Keiji
    Hashiguchi, Yojiro
    ONCOLOGY, 2017, 92 (06) : 360 - 370
  • [4] Molecular Signatures That Predict Response to Azacitidine Treatment for Myelodysplastic Syndromes
    Nannya, Yasuhito
    Takeda, June
    Sato, Shinya
    Shiozawa, Yusuke
    Shiraishi, Yuichi
    Kataoka, Keisuke
    Chiba, Kenichi
    Tanaka, Hiroko
    Chiba, Shigeru
    Asou, Norio
    Kiyoi, Hitoshi
    Imai, Kiyotoshi
    Hirase, Chikara
    Dobashi, Nobuaki
    Kiguchi, Toru
    Nakao, Shinji
    Ohyashiki, Kazuma
    Miyazaki, Yasushi
    Naoe, Tomoki
    Makishima, Hideki
    Miyano, Satoru
    Yoshida, Kenichi
    Ogawa, Seishi
    BLOOD, 2017, 130
  • [5] Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer
    Wu, Jianhong
    Li, Guangxin
    Wang, Zeyou
    Yao, Yongliang
    Chen, Rui
    Pu, XiongYong
    Wang, Jianjun
    DISEASE MARKERS, 2015, 2015
  • [6] Circulating microRNA-21 as noninvasive predictive biomarker for response in cancer immunotherapy
    Wang, Zhiyu
    Han, Jinxiang
    Cui, Yazhou
    Fan, Kaixi
    Zhou, Xiaoyan
    MEDICAL HYPOTHESES, 2013, 81 (01) : 41 - 43
  • [7] Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
    Tomimaru, Yoshito
    Eguchi, Hidetoshi
    Nagano, Hiroaki
    Wada, Hiroshi
    Kobayashi, Shogo
    Marubashi, Shigeru
    Tanemura, Masahiro
    Tomokuni, Akira
    Takemasa, Ichiro
    Umeshita, Koji
    Kanto, Tatsuya
    Doki, Yuichiro
    Mori, Masaki
    JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 167 - 175
  • [8] MicroRNA-21 Regulates the Invasion and Metastasis in Cholangiocarcinoma and May Be a Potential Biomarker for Cancer Prognosis
    Huang, Qiang
    Liu, Lei
    Liu, Chen-Hai
    You, Hao
    Shao, Feng
    Xie, Fang
    Lin, Xian-Sheng
    Hu, San-Yuan
    Zhang, Chuan-Hai
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 829 - 834
  • [9] MicroRNA-21 as a potential colon and rectal cancer biomarker
    Tao Li
    Mei Ha Leong
    Bruce Harms
    Gregory Kennedy
    Lin Chen
    World Journal of Gastroenterology, 2013, (34) : 5615 - 5621
  • [10] MicroRNA-21 as a potential colon and rectal cancer biomarker
    Li, Tao
    Leong, Mei Ha
    Harms, Bruce
    Kennedy, Gregory
    Chen, Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (34) : 5615 - 5621
12345